Trials / Unknown
UnknownNCT02799992
Pseudo-PDT in Central Serous Chorioretinopathy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- Sponsor
- Università degli Studi di Brescia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute central serous chorioretinopathy (CSC) is a common disorder in middle-aged patients, characterized by serous retinal detachment in the macular region. We evaluated half-dose verteporfin photodynamic therapy (hd-PDT) versus 689 nm laser treatment in chronic CSC. Twenty-two eyes of 22 patients with symptomatic chronic CSC were randomized in a 1:1 ratio to receive hd-PDT (group 1) or 689-LT delivering 95 J/cm2 by application of an intensity of 805 mW/cm2 over 118 seconds. Best-corrected visual acuity (BCVA) and spectral-domain optical coherence tomography findings were compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 689 nm Laser Treatment of the Macula | |
| PROCEDURE | Half Dose Photodynamic Therapy |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
- First posted
- 2016-06-15
- Last updated
- 2016-06-15
Source: ClinicalTrials.gov record NCT02799992. Inclusion in this directory is not an endorsement.